These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22284353)

  • 21. Geometric similarities of protein-protein interfaces at atomic resolution are only observed within homologous families: an exhaustive structural classification study.
    Kinjo AR; Nakamura H
    J Mol Biol; 2010 Jun; 399(3):526-40. PubMed ID: 20417638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural analysis of the human Rad51 protein-DNA complex filament by tryptophan fluorescence scanning analysis: transmission of allosteric effects between ATP binding and DNA binding.
    Renodon-Cornière A; Takizawa Y; Conilleau S; Tran V; Iwai S; Kurumizaka H; Takahashi M
    J Mol Biol; 2008 Nov; 383(3):575-87. PubMed ID: 18761348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational approaches to identifying and characterizing protein binding sites for ligand design.
    Henrich S; Salo-Ahen OM; Huang B; Rippmann FF; Cruciani G; Wade RC
    J Mol Recognit; 2010; 23(2):209-19. PubMed ID: 19746440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing structural adaptivity at PPI interfaces with small molecules.
    Wilson CG; Arkin MR
    Drug Discov Today Technol; 2013 Dec; 10(4):e501-8. PubMed ID: 24451641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Established and emerging trends in computational drug discovery in the structural genomics era.
    Taboureau O; Baell JB; Fernández-Recio J; Villoutreix BO
    Chem Biol; 2012 Jan; 19(1):29-41. PubMed ID: 22284352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular perspective: RAD51 and BRCA2.
    Goodsell DS
    Stem Cells; 2005 Oct; 23(9):1434-5. PubMed ID: 16210413
    [No Abstract]   [Full Text] [Related]  

  • 28. Discarding functional residues from the substitution table improves predictions of active sites within three-dimensional structures.
    Gong S; Blundell TL
    PLoS Comput Biol; 2008 Oct; 4(10):e1000179. PubMed ID: 18833291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based drug discovery and protein targets in the CNS.
    Hubbard RE
    Neuropharmacology; 2011 Jan; 60(1):7-23. PubMed ID: 20673774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein-protein interactions as targets for small molecule drug discovery.
    Fry DC
    Biopolymers; 2006; 84(6):535-52. PubMed ID: 17009316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lead generation and examples opinion regarding how to follow up hits.
    Orita M; Ohno K; Warizaya M; Amano Y; Niimi T
    Methods Enzymol; 2011; 493():383-419. PubMed ID: 21371599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct roles of overlapping and non-overlapping regions of hub protein interfaces in recognition of multiple partners.
    Dasgupta B; Nakamura H; Kinjo AR
    J Mol Biol; 2011 Aug; 411(3):713-27. PubMed ID: 21723293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery.
    Laskowski RA; Swindells MB
    J Chem Inf Model; 2011 Oct; 51(10):2778-86. PubMed ID: 21919503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using a fragment-based approach to target protein-protein interactions.
    Scott DE; Ehebauer MT; Pukala T; Marsh M; Blundell TL; Venkitaraman AR; Abell C; Hyvönen M
    Chembiochem; 2013 Feb; 14(3):332-42. PubMed ID: 23344974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SCOWLP: a web-based database for detailed characterization and visualization of protein interfaces.
    Teyra J; Doms A; Schroeder M; Pisabarro MT
    BMC Bioinformatics; 2006 Mar; 7():104. PubMed ID: 16512892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural features of protein-nucleic acid recognition sites.
    Nadassy K; Wodak SJ; Janin J
    Biochemistry; 1999 Feb; 38(7):1999-2017. PubMed ID: 10026283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting ligand-induced conformational changes in proteins: essence, advancements, implications and future challenges.
    Ahmad E; Rabbani G; Zaidi N; Khan MA; Qadeer A; Ishtikhar M; Singh S; Khan RH
    J Biomol Struct Dyn; 2013; 31(6):630-48. PubMed ID: 22888832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.